Massimilano Colao - Mar 2, 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Commercial Officer
Signature: /s/ Massimiliano Colao
Stock symbol: AUPH
Transactions as of: Mar 2, 2022
Transactions value $: -$38,492
Form type: 4
Date filed: 3/4/2022, 03:11 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Award	$0	+8.5K	+103.66%	$0.00	16.7K	Mar 2, 2022	Direct	F1
transaction	AUPH	Common Stock	Sale	-$38.5K	-3.21K	-19.19%	$12.01	13.5K	Mar 2, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUPH	Restricted Stock Unit	Award	$0	+104K		$0.00	104K	Mar 2, 2022	Common Shares	104K		Direct	F3
transaction	AUPH	Stock Option (right to buy)	Award	$0	+178K		$0.00	178K	Mar 2, 2022	Common Stock	178K	$12.01	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 18, 2021, the Reporting Person was granted stock based performance awards ("Performance Awards") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration.
F2	Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards.
F3	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date.
F4	One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.